Tilray Brands (TLRY) Other financing activities (2019 - 2025)

Tilray Brands' (TLRY) quarterly Other financing activities came in at $2.4 million in Q4 2025, up 59015.82% on a QoQ basis from $4000.0 in Q3 2020.

Tilray Brands (TLRY) Other financing activities (2019 - 2025) Analysis & Trends

Tilray Brands (TLRY) has 3 years of Other financing activities data on file, last reported at $2.4 million in Q4 2025.

Quarterly Other financing activities changed N/A year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through May 2026 was $2.4 million (up 345.55% YoY) and the FY2026 annual result came in at $2.4 million, changed N/A from the prior year.
Other financing activities advanced to $2.4 million in Q4 2025, from $4000.0 in the prior quarter.
In the past five years, Other financing activities ranged from a high of $2.4 million in Q4 2025 to a low of $2.4 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	Tilray Brands	523.93 Mn	289.30 Mn	90.52 Mn

Download Data